Sponsor
Pharma sector: Firms to clock 11% sales, EBITDA growth in Q1FY26
Posted
India's pharmaceutical sector is projected to experience an 11% year-on-year growth in sales and EBITDA for Q1 FY26, driven by strong market performance across various regions. The hospital segment is expected to lead with a 17% growth, while diagnostics firms anticipate a 14% sales increase. Government initiatives and investments in R&D further support the industry's optimistic outlook.
Zoeken
Categorieën
- National
- International
- Business
- Technology
- Health
- Onderwijs
- Sports
- Entertainment
- Travel
- Environment
- Science
- Law
- Agriculture
- Real Estate
- Opinion
- Religion
- Weather
- Automotive
- Social Issues
- Culture
- Sci-Fi & Future
Read More
PM Oli to address House of Representatives today
KATHMANDU: Prime Minister KP Sharma Oli is scheduled to address the House of Representatives this...
Suicide or murder? DOJ, FBI drop big update on Jeffrey Epstein death; debunk conspiracy theories
A DOJ and FBI memo concludes Jeffrey Epstein's death was a suicide, dismissing murder and...
MLC: Gous, Maxwell power WF to six-wicket win over MINY; finish top two
Andries Gous's composed innings and Glenn Maxwell's excellent bowling performance led Washington...
'Essence of the game goes missing': Shubman Gill slams Dukes ball, flat pitches
Shubman Gill, despite his stellar batting performance in the series with nearly 600 runs, has...
© 2025 Dununu.com : Circle of Life - Santan Social Network
Dutch
